Initial results from the first prospective, randomized, multicenter trial of home-based monitoring of ICD function have shown that the technology reduces the follow-up burden by almost 50%. Heartwire
Observational studies may take on a life of their own in the literature, hanging on even after they have been discredited by randomized controlled trials, an analysis suggests. Heartwire
The FDA has approved revisions to the safety labeling for a fluocinolone acetonide intravitreal implant, levothyroxine sodium tablets, and amlodipine plus valsartan tablets. Medscape Medical News
